These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15760071)

  • 1. Effect of starting material particle size on its agglomeration behavior in high shear wet granulation.
    Badawy SI; Hussain MA
    AAPS PharmSciTech; 2004 May; 5(3):e38. PubMed ID: 15760071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of drug substance particle size on the characteristics of granulation manufactured in a high-shear mixer.
    Badawy SI; Lee TJ; Menning MM
    AAPS PharmSciTech; 2000 Nov; 1(4):E33. PubMed ID: 14727898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melt granulation of pharmaceutical powders: a comparison of high-shear mixer and fluidised bed processes.
    Passerini N; Calogerà G; Albertini B; Rodriguez L
    Int J Pharm; 2010 May; 391(1-2):177-86. PubMed ID: 20214959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrusion granulation and high shear granulation of different grades of lactose and highly dosed drugs: a comparative study.
    Keleb EI; Vermeire A; Vervaet C; Remon JP
    Drug Dev Ind Pharm; 2004 Jul; 30(6):679-91. PubMed ID: 15285342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-step granulation/tabletting of different grades of lactose: a comparison with high shear granulation and compression.
    Keleb EI; Vermeire A; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2004 Jul; 58(1):77-82. PubMed ID: 15207540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Form conversion of anhydrous lactose during wet granulation and its effect on compactibility.
    Shah KR; Hussain MA; Hubert M; Farag Badawy SI
    Int J Pharm; 2008 Jun; 357(1-2):228-34. PubMed ID: 18374527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of drug substance material properties in the processibility and performance of a wet granulated product.
    Vemavarapu C; Surapaneni M; Hussain M; Badawy S
    Int J Pharm; 2009 Jun; 374(1-2):96-105. PubMed ID: 19446765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of Stokes deformation number as a predictive tool for material exchange behaviour of granules in the 'equilibrium phase' in high shear granulation.
    Bouwman AM; Visser MR; Meesters GM; Frijlink HW
    Int J Pharm; 2006 Aug; 318(1-2):78-85. PubMed ID: 16713144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the physicochemical properties and compaction behavior of melt granules produced in microwave-induced and conventional melt granulation in a single pot high shear processor.
    Loh ZH; Sia BY; Heng PW; Lee CC; Liew CV
    AAPS PharmSciTech; 2011 Dec; 12(4):1374-83. PubMed ID: 22005957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of metronidazole particle properties on granules prepared in a high-shear mixer-granulator.
    Di Martino P; Censi R; Malaj L; Martelli S; Joiris E; Barthélémy C
    Drug Dev Ind Pharm; 2007 Feb; 33(2):121-31. PubMed ID: 17454043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining formulation and process aspects for optimizing the high-shear wet granulation of common drugs.
    Cavinato M; Andreato E; Bresciani M; Pignatone I; Bellazzi G; Franceschinis E; Realdon N; Canu P; Santomaso AC
    Int J Pharm; 2011 Sep; 416(1):229-41. PubMed ID: 21763764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous twin screw granulation: influence of process variables on granule and tablet quality.
    Vercruysse J; Córdoba Díaz D; Peeters E; Fonteyne M; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Sep; 82(1):205-11. PubMed ID: 22687571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug distribution in wet granulation: foam versus spray.
    Tan MX; Nguyen TH; Hapgood KP
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1389-400. PubMed ID: 23057532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact milling of pharmaceutical agglomerates in the wet and dry states.
    Schenck LR; Plank RV
    Int J Pharm; 2008 Feb; 348(1-2):18-26. PubMed ID: 17804181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between inhomogeneity phenomena and granule growth mechanisms in a high-shear mixer.
    van den Dries K; Vromans H
    Int J Pharm; 2002 Oct; 247(1-2):167-77. PubMed ID: 12429495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation on the correlation between drug dissolution properties and the growth behaviour of granules in high shear mixer.
    Guo Z; Ma M; Hao Y; Jiang T; Wang S
    J Pharm Pharmacol; 2011 Dec; 63(12):1548-58. PubMed ID: 22060285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the effect of wet granulation on microcrystalline cellulose particle structure and performance.
    Badawy SI; Gray DB; Hussain MA
    Pharm Res; 2006 Mar; 23(3):634-40. PubMed ID: 16382277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of granule fracture strength as a function of impeller tip speed and granule size for a novel reverse-phase wet granulation process.
    Wade JB; Martin GP; Long DF
    Int J Pharm; 2015 Jul; 488(1-2):95-101. PubMed ID: 25888799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shear-induced APAP de-agglomeration.
    Llusa M; Levin M; Snee RD; Muzzio FJ
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1487-95. PubMed ID: 19929208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.